Heart Failure With “Mid-Range” Ejection Fraction—New Opportunities

Journal of Cardiac Failure

Volumn 22, Issue 10, 2016, Pages 769-771

  Lund, Lars H ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; IRBESARTAN; PERINDOPRIL; PLACEBO; SPIRONOLACTONE;

ACUTE CORONARY SYNDROME; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DEMOGRAPHY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART FAILURE WITH MID RANGE EJECTION FRACTION; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; AGED; CAUSE OF DEATH; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; EUROPE; FEMALE; HEART STROKE VOLUME; MALE; MEDICAL SOCIETY; MORTALITY; PHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; EUROPE; FEMALE; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 84979788561     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.07.439     Document Type: Editorial

References (12)

1. 1 Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G., Coats, A.J., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016, 10.1093/eurheartj/ehw128.
2. 2 Yeboah, J., Rodriguez, C.J., Qureshi, W., Liu, S., Carr, J.J., Lima, J.A., et al. Prognosis of low normal left ventricular ejection fraction in an asymptomatic population-based adult cohort: the multiethnic study of atherosclerosis. J Card Fail, 2016, 10.1016/j.cardfail.2016.03.013.
3. 3 Dougherty, A.H., Naccarelli, G.V., Gray, E.L., Hicks, C.H., Goldstein, R.A., Congestive heart failure with normal systolic function. Am J Cardiol 54 (1984), 778–782.
4. 4 Campbell, R.T., Jhund, P.S., Castagno, D., Hawkins, N.M., Petrie, M.C., McMurray, J.J., What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?. J Am Coll Cardiol 60 (2012), 2349–2356.
5. 5 Borlaug, B.A., Redfield, M.M., Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123 (2011), 2006–2013 discussion 2014.
6. 6 Solomon, S.D., Anavekar, N., Skali, H., McMurray, J.J., Swedberg, K., Yusuf, S., et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112 (2005), 3738–3744.
7. 7 Lam, C.S., Solomon, S.D., The middle child in heart failure: heart failure with mid-range ejection fraction (40–50%). Eur J Heart Fail 16 (2014), 1049–1055.
8. 8 Lund, L.H., Benson, L., Dahlström, U., Edner, M., Friberg, L., Association between use of beta-blockers and outcomes in patients with heart failure and preserved ejection fraction. JAMA 312 (2014), 2008–2018.
9. 9 Rogers, J.K., Pocock, S.J., McMurray, J.J., Granger, C.B., Michelson, E.L., Ostergren, J., et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Fail 16 (2014), 33–40.
10. 10 Solomon, S.D., Claggett, B., Lewis, E.F., Desai, A., Anand, I., Sweitzer, N.K., et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J, 2015, 10.1093/eurheartj/ehv464.
11. 11 Lund, L.H., Benson, L., Dahlstrom, U., Edner, M., Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA 308 (2012), 2108–2117.
12. 12 Paulus, W.J., Tschope, C., A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62 (2013), 263–271.